SUSTAINED EFFICACY AND LONG-TERM SAFETY OF ERENUMAB IN PATIENTS WITH EPISODIC MIGRAINE: RESULTS OF A 5-YEAR, OPEN-LABEL EXTENSION STUDY

被引：0

作者：

Ashina, Messoud ^{[1
]}

Goadsby, Peter J. ^{[2
,3
]}

Reuter, Uwe ^{[4
]}

Silberstein, Stephen ^{[5
]}

Dodick, David W. ^{[6
]}

Xue, Fei ^{[7
]}

Zhang, Feng ^{[7
]}

Cheng, Sunfa ^{[7
]}

Chou, Denise E. ^{[7
]}

Lima, Gabriel Paiva da Silva ^{[7
]}

机构：

[1] Univ Copenhagen, Fac Hlth & Med Sci, Rigshosp Glostrup, Dept Neurol,Danish Headache Ctr, Copenhagen, Denmark

[2] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA

[3] Kings Coll London, NIHR Wellcome Trust Kings Clin Res Facil, London, England

[4] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany

[5] Thomas Jefferson Univ, Jefferson Headache Ctr, Philadelphia, PA 19107 USA

[6] Mayo Clin, Dept Neurol, Scottsdale, AZ USA

[7] Amgen Inc, Thousand Oaks, CA 91320 USA

来源：

CEPHALALGIA | 2020年 / 40卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

MTV20-DP-0

引用

页码：60 / 61

页数：2

共 50 条

[21] Assessment of the long-term safety and efficacy of erenumab during open-label treatment of subjects with chronic migraine
Tepper, Stewart
Ashina, Messoud
Reuter, Uwe
Brandes, Jan L.
Dolezil, David
Silberstein, Stephen
Winner, Paul
Zhang, Feng
Cheng, Sunfa
Mikol, Daniel
JOURNAL OF HEADACHE AND PAIN, 2018, 19
[22] Long-Term Safety and Efficacy of Rotigotine in Patients with Idiopathic RLS: 5-Year Results from a Prospective Multinational Open-Label FollowUp Study
Hogl, Birgit
Trenkwalder, Claudia
Garcia-Borreguero, Diego
Kohnen, Ralf
Poewe, Werner
Stiasny-Kolster, Karin
Bauer, Lars
Fichtner, Andreas
Schollmayer, Erwin
Oertel, Wolgang
NEUROLOGY, 2010, 74 (09) : A106 - A106
[23] Long-Term Efficacy and Safety of Romiplostim for the Treatment of Patients with Chronic Immune Thrombocytopenia (ITP): 5-Year Update From An Open-Label Extension Study
Bussel, James B.
Kuter, David J.
Newland, Adrian
de Wolf, Joost T. M.
Wasser, Jeffrey
Chang, Paul
Nie, Kun
Berger, Dietmar
BLOOD, 2009, 114 (22) : 285 - 285
[24] Assessment of the Long-Term Safety and Efficancy of Erenumab During Open-Label Treatment of Patients With Chronic Migraine
Tepper, Stewart J.
Ashina, Messoud
Reuter, Uwe
Brandes, Jan L.
Dolezil, David
Silberstein, Stephen
Winner, Paul
Zhang, Feng
Cheng, Sunfa
Mikol, Daniel D.
NEUROLOGY, 2019, 92 (15)
[25] Sustained efficacy and long-term safety of oxcarbazepine: One-year open-label extension of a study in refractory partial epilepsy
Beydoun, A
Sachdeo, RC
Kutluay, E
McCague, K
D'Souza, J
EPILEPSIA, 2003, 44 (09) : 1160 - 1165
[26] Long-Term Safety and Efficacy of Bimekizumab in Patients with Active Ankylosing Spondylitis: 5-Year Results from a Phase 2b Study and Its Open-Label Extension
Deodhar, Atul
Navarro-Compan, Victoria
Poddubnyy, Denis
Gensler, Lianne
Ramiro, Sofia
Tomita, Tetsuya
Marzo-Ortega, Helena
Fleurinck, Carmen
Vaux, Thomas
Massow, Ute
van der Heijde, Desiree
Baraliakos, Xenofon
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1014 - 1017
[27] Long-term treatment with lasmiditan in patients with migraine: Results from the open-label extension of the CENTURION study
Ashina, M.
Roos, C.
Ayer, D. W.
Ruff, D.
Krege, J. H.
Li, L. Q.
Komori, M.
HEADACHE, 2022, 62 : 113 - 114
[28] Long-Term Treatment With Lasmiditan in Patients With Migraine: Results From the Open-Label Extension of the CENTURION Study
Ashina, M.
Roos, C.
Ayer, D.
Ruff, D.
Krege, J.
Li, L. Q.
Komori, M.
JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
[29] ABP 501 Long-Term Safety/Efficacy: Interim Results from an Open-Label Extension Study
Cohen, Stanley
Pablos, Jose L.
Zhang, Nan
Rizzo, Warren
Muller, Gerhard
Padmanaban, Devi
Kivitz, Alan
Matsumoto, Alan K.
Kaur, Primal
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[30] LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
Banerji, A.
Hao, J.
Yu, M.
Bernstein, J.
Johnston, D.
Riedl, M.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S21 - S21

← 1 2 3 4 5 →